Moreover, early-life inflammation is shaped by a complex interplay of perinatal factors, infections, gut health, microbiota, and oxidative stress, so systemic markers such as CRP and AGP may miss subtle or localized benefits of the intervention. This evidence concerns the gene CRP and infection.